The Fast Track (Priority) Review pathway has been developed by the Sri Lankan National Medicines Regulatory Authority (NMRA) of Sri Lanka.

This pathway accelerates the regulatory review process.

It is an abridged review (a reliance pathway).

When relevant, the agency relies on prior decisions from Australia Canada Europe Japan Malaysia Netherlands Singapore South Korea Switzerland United Kingdom United States

The application submitted for registration will be screened chronologically according to date of submission to the Authority, and the applicant will be notified of the results of its evaluation within 28 working days of its submission to the Authority